This call to action by President George W. Bush was made on July 3, 2012, in Ngungu, Kabwe, Zambia.GlaxoSmithKline has heeded this call and is...
This call to action by President George W. Bush was made on July 3, 2012, in Ngungu, Kabwe, Zambia.
GlaxoSmithKline has heeded this call and is doing its part to make the future a little brighter for 10,000 adolescent girls as well as hundreds of patients in pain with cancer in Zambia. Following the Africa 2012 Trip with President and Mrs. Bush and other Pink Ribbon Red Ribbon (PRRR) partners, the pharmaceutical company agreed to provide all of the pledged vaccine donation, worth $1 million to support prevention of HPV infection for 10,000 adolescent girls, to Zambia. In addition, GlaxoSmithKline agreed to donate up to 1 million doses of morphine sulfate active powder every year for three years to help with pain management among patients with cancer in Zambia. PRRR was launched in September 2011 by the George W. Bush Institute, the President’s Emergency Plan for AIDS Relief (PEPFAR), Susan G. Komen for the Cure, and UNAIDS to leverage public and private investments in global health to combat cervical and breast cancer – two of the leading causes of cancer death in women – in developing nations in Sub-Saharan Africa and Latin America. The initiative includes GlaxoSmithKline and other corporate organizations. The GlaxoSmithKline donation is a prime example of how PRRR is leveraging private investments to complement national cancer strategies and resources. I look forward to providing regular updates of the transformative efforts – and brighter futures – generated by PRRR’s innovative partnership model.
This post was written by Doyin Oluwole, MD, FRCP, the founding Executive Director of Pink Ribbon Red Ribbon, based at the George W. Bush Institute.
